Mishcon de Reya page structure
Site header
Main menu
Main content section

Mishcon de Reya advises on the acquisition of J+D Forecasting by Evaluate

Posted on 6 February 2024

Mishcon de Reya's Private Equity team has advised J+D Forecasting CEO and Founder David James on the acquisition by Evaluate, a Norstella company backed by private equity investors Hg Capital, WCAS and Warburg Pincus.

J+D Forecasting is a UK-based leading provider of forecasting solutions in the pharma space, and currently works with several blue-chip pharma companies, including Gilead Sciences, Pfizer, Merck, Janssen, GSK and Eli Lilly.

Norstella will continue advancing its forecasting portfolio by integrating J+D Forecasting's cloud-based and software forecasting solutions and employing GenAI to synthesise insights from various models, creating a comprehensive one-stop solution for all forecasting needs.

The team at Mishcon de Reya was led by Nadim Meer and comprised lawyers from the firm's Private Equity and Tax teams, including James Paterson, Karine Bashardust, Jack Crawford, Olivia Woodhead, Angelika Velickovska, John Skoulding and Stephen Elhabbal.

Nadim Meer, Head of Private Equity at Mishcon de Reya, commented: ”David has built an excellent business and combining J+D with the Norstella platform makes sense for all parties. It was a pleasure working with David and his deal team and I’m sure J+D will be a great success within the Norstella platform."

David James added: "This was the first time I have been involved in such a process and there was a lot to take in, between the sale documents and the ongoing equity arrangements. I couldn’t have been in better hands. The Mishcon Private Equity team were great to work with and were with me every step of the way."

How can we help you?

How can we help you?

Subscribe: I'd like to keep in touch

If your enquiry is urgent please call +44 20 3321 7000

Crisis Hotline

I'm a client

I'm looking for advice

Something else